Peregrine Pharmaceuticals Announces Receipt of Notice From NASDAQ

Peregrine Pharmaceuticals Announces Receipt of Notice From NASDAQ

[at noodls] – TUSTIN, CA — (Marketwire) — 11/14/12 — Peregrine Pharmaceuticals (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of … more

View todays social media effects on PPHM

View the latest stocks trending across Twitter. Click to view dashboard

Share this post